We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Women with Average-Risk for Breast Cancer Could Benefit from MRI Screening

By HospiMedica International staff writers
Posted on 09 Oct 2015
The results of a new study suggest that periodic screening of women with average risk of breast cancer, using Magnetic Resonance Imaging (MRI), improves the detection of small, high-grade breast cancers.

The study was presented in by Christiane Kuhl, MD, University of Aachen (Aachen, Germany; www.rwth-aachen.de) at the 2015 American Society of Clinical Oncology (ASCO; San Francisco, USA) Breast Cancer Symposium.

In the study 2,120 women with average risk of breast cancer, were randomized, and underwent screening using breast MRI and mammography every 12, 24, or 36 months. More...
The women in the trial had a mean age of 53.8 years, and there were 3,861 completed screening rounds. MRI screening resulted in Breast Imaging-Reporting and Data System (BI-RADS) I or II findings in 91% of the screens, BI-RADS III in 175 screens, and BI-RADs IV or V finding in 171 screens.

The study achieved an overall detection rate of 28.8 per 1,000 women, and found 61 cancers, 60 of which were detected only by MRI. The study found 20 (32.8%) DCIS cancers, 67.2% invasive cancers, 42.6% high grade, and 32.8% estrogen receptor (ER)/progesterone receptor (PR) negative cancers. No zero interval cancers were found.

The researchers concluded that MRI screening every three years could be enough to establish a zero interval cancer rate, and improve detection of some cancers.

Dr. Kuhl, said, “Mammography consistently fails to detect rapidly growing cancers, which will then be detected as ‘interval cancers.’” MRI has so far been used only in high-risk women; there is no evidence of its use in average-risk women.”

Related Links:

University of Aachen



Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Rapid Sepsis Test
SeptiCyte RAPID
New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.